Skip to main content
SpringerLink
Log in

Are hsCRP Levels and LDL/HDL Ratio Better and Early Markers to Unmask Onset of Dyslipidemia and Inflammation in Asymptomatic Subclinical Hypothyroidism?

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

The implications of subclinical hypothyroidism (SCH) are many amongst which the most important is progression to overt hypothyroidism. Other debatable aspects are its association with cardiovascular risk, neuromuscular and psychiatric dysfunction, increased predisposition to developing metabolic syndrome and an underlying pro-inflammatory state. We aimed to study the lipid profile, lipoprotein(a) [Lp(a)] and hsCRP levels and insulin resistance in a group of patients with SCH in a referral hospital and see if any significant differences exist between them and euthyroids. This is a case–control study where the selection of controls and cases was based on the thyroid profile. Subjects were selected on their visit to clinical biochemistry lab for thyroid function tests. 33 euthyroids were taken as controls (Group I) and 38 patients comprising of subclinical hypothyroids were grouped as cases (Group II). Serum thyroid stimulating hormone (TSH) was in the range of 0.5–5.0 mIU/L for euthyroids and for subclinical hypothyroids the concentration of TSH was more than 5 mIU/L. The concentration of tri-iodothyronine (T3) and thyroxine (T4) were in normal reference range in both the groups. Individual lipid profile parameters failed to show a significant p value between cases and controls. The LDL/HDL ratio was highly significant (p value < 0.0001) and hsCRP was also statistically between the two groups (p value = 0.0054). Lp(a) and insulin resistance did not differ significantly. SCH is a common disorder that frequently progresses to overt hypothyroidism. This study underlines the importance of LDL/HDL ratio rather than measurement of individual lipid profile parameters in bringing to light the dyslipidemic state associated with SCH. Moreover the use of hsCRP to detect an underlying pro-inflammatory state in SCH can also be emphasized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Biondi B, Cooper DS. The clinical significance of thyroid dysfunction. Endocr Rev. 2008;29(1):76–131.

    Article  PubMed  CAS  Google Scholar 

  2. Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009;84(1):65–71.

    Article  PubMed  Google Scholar 

  3. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55–68.

    Article  CAS  Google Scholar 

  4. Díez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004;89(10):4890–7.

    Article  PubMed  Google Scholar 

  5. Elder J, McClelland A, O’Reilly DS, Packard CJ, Series JJ, Shepherd J. The relationship between serum cholesterol and serum thyrotropin, thyroxine and tri-iodothyronine concentrations in suspected hypothyroidism. Ann Clin Biochem. 1990;27:110–3.

    PubMed  Google Scholar 

  6. Staub J-J, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med. 1992;92:631.

    Article  PubMed  CAS  Google Scholar 

  7. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. J Am Med Assoc. 2006;295(9):1033–41.

    Article  CAS  Google Scholar 

  8. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med. 2006;119(7):541–51.

    Article  PubMed  Google Scholar 

  9. Ochs N, Auer R, Bauer D, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148(11):832–45.

    PubMed  Google Scholar 

  10. Hueston WJ, King DE, Geesey ME. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism. Clin Endocrinol. 2005;63(5):582–7.

    Article  CAS  Google Scholar 

  11. Duntas LH, Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors: what is the evidence? Thyroid. 2007;17(11):1075–84.

    Article  PubMed  CAS  Google Scholar 

  12. Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000;7:127–30.

    Article  PubMed  CAS  Google Scholar 

  13. Leung AS, Miller LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol. 1993;81:349–53.

    PubMed  CAS  Google Scholar 

  14. Lincoln SR, Ke RW, Kutteh WH. Screening for hypothyroidism in infertile women. J Reprod Med. 1999;44:455–7.

    PubMed  CAS  Google Scholar 

  15. Baldini IM, Vita A, Mauri MC, et al. Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:925–35.

    Article  PubMed  CAS  Google Scholar 

  16. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of l-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007;92(5):1715–23.

    Article  PubMed  CAS  Google Scholar 

  17. Lopez-Majano V, Abraira C. Laboratory diagnosis in thyroid disease. Ill Med J. 1981;159(2):95–101.

    CAS  Google Scholar 

  18. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7:481–93.

    Article  CAS  Google Scholar 

  19. Cooper DS. Subclinical hypothyroidism. N Engl J Med. 2001;345(4):260–5.

    Article  PubMed  CAS  Google Scholar 

  20. Ayala A, Danese MD, Ladenson PW. When to treat mild hypothyroidism. Endocrinol Metab Clin N Am. 2000;29:399–415.

    Article  CAS  Google Scholar 

  21. Bhaskaran S, Kumar H, Nair V, et al. Subclinical hypothyroidism: indications for thyroxine therapy. Thyr Res Pract. 2004;1(3):10–4.

    Google Scholar 

  22. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1995;7:481–93.

    Article  Google Scholar 

  23. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–99.

    Article  PubMed  CAS  Google Scholar 

  24. Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, Braverman LE. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab. 2002;87:3221–6.

    Article  PubMed  CAS  Google Scholar 

  25. Diez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004;89:4890–7.

    Article  PubMed  CAS  Google Scholar 

  26. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. J Am Med Assoc. 2004;292:2591–9.

    Article  CAS  Google Scholar 

  27. Michalopoulou G, Alevizaki M, Piperingos G, Mitsibounas D, Mantzos E, Adamopoulos P, Koutras DA. High serum cholesterol levels in persons with’ high-normal’ TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol. 1998;138:141–5.

    Article  PubMed  CAS  Google Scholar 

  28. Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. J Intern Med. 2006;260:53–61.

    Article  PubMed  CAS  Google Scholar 

  29. Asvold BO, Vatten LJ, Nilsen TI, Bjøro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol. 2007;156(2):181–6.

    Article  PubMed  Google Scholar 

  30. Bakker SJ, ter Maaten JC, Popp-Snijders C, Slaets JP, Heine RJ, Gans RO. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab. 2001;86:1206–11.

    Article  PubMed  CAS  Google Scholar 

  31. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol. 1977;7:495–508.

    Article  CAS  Google Scholar 

  32. Hueston WJ, Pearson WS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med. 2004;2:351–5.

    Article  PubMed  Google Scholar 

  33. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132:270–8.

    PubMed  CAS  Google Scholar 

  34. Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, Usa T, Ashizawa K, Yokoyama N, Maeda R, Nagataki S, Eguchi K, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004;89:3365–70.

    Article  PubMed  CAS  Google Scholar 

  35. Lindeman RD, Schade DS, LaRue A, Romero LJ, Liang HC, Baumgartner RN, Koehler KM, Garry PJ. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc. 1999;47:703–9.

    PubMed  CAS  Google Scholar 

  36. Bindels AJ, Westendorp RG, Frolich M, Seidell JC, Blokstra A, Smelt AH. The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding? Clin Endocrinol. 1999;50:217–20.

    Article  CAS  Google Scholar 

  37. Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12:287–93.

    Article  PubMed  CAS  Google Scholar 

  38. Santi A, Duarte MM, Moresco RN, et al. Association between thyroid disease, lipids, oxidative stress biomarkers in overt hypothyroidism. Clin Chem Lab Med. 2010;48(11):1635–9.

    Article  PubMed  CAS  Google Scholar 

  39. Fatourechi V. Subclinical hypothyroidism: when to treat, when to watch? Consultant. 2004;44(4):533–9.

    Google Scholar 

  40. Richmond W. When and how to measure lipids and their role in CHD risk prediction. Br J Diabetes Vasc Dis. 2003;3:191–8.

    Article  CAS  Google Scholar 

  41. Fernandez M, Webb D. The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J Am Coll Nutr. 2008;27(1):1–5.

    PubMed  CAS  Google Scholar 

  42. Tian L, Fu M. The relationship between high density lipoprotein subclass profile and plasma lipids concentrations. Lipids Health Dis. 2010;9:118.

    Article  PubMed  Google Scholar 

  43. Kung AW, Pang RW, Janus ED. Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol. 1995;43:445–9.

    Article  CAS  Google Scholar 

  44. Tsimihodimos V, Bairaktari E, Tzallas C, Miltiadus G, Liberopoulos E, Elisaf M. The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic. Thyroid. 1999;9:365–8.

    Article  PubMed  CAS  Google Scholar 

  45. Caraccio N, Ferranini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab. 2002;87:1533–8.

    Article  PubMed  CAS  Google Scholar 

  46. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf). 2004;61:232–8.

    Article  CAS  Google Scholar 

  47. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Muller B. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis. 2003;166:379.

    Article  PubMed  CAS  Google Scholar 

  48. Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K. Subclinical hypothyroidism may be associated with elevated high-sensitive creactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J. 2005;52(1):89–94.

    Article  PubMed  CAS  Google Scholar 

  49. Singh S, Singh K. Alterations in lipid fraction levels in subclinical hypothyroidism in north Indian population. Indian J Fundam Appl Life Sci. 2011;1(2):127–32.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Maulana Azad Medical College, Pathology Block, Room No. 203/204, 2nd Floor, New Delhi, 110002, India

    Mala Mahto, Baidarbhi Chakraborthy, Srinivas H. Gowda, Harneet Kaur & Pramod Lali

  2. Department of Pharmacology, Maulana Azad Medical College, New Delhi, India

    Gaurav Vishnoi

Authors
  1. Mala Mahto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Baidarbhi Chakraborthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Srinivas H. Gowda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Harneet Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gaurav Vishnoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pramod Lali
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mala Mahto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mahto, M., Chakraborthy, B., Gowda, S.H. et al. Are hsCRP Levels and LDL/HDL Ratio Better and Early Markers to Unmask Onset of Dyslipidemia and Inflammation in Asymptomatic Subclinical Hypothyroidism?. Ind J Clin Biochem 27, 284–289 (2012). https://doi.org/10.1007/s12291-012-0206-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-012-0206-y

Keywords

Search

Navigation